Novo Nordisk (NOVOB DC) says Wegovy (Semaglutide 7.2mg) has been approved in the US, providing 20.7% mean weight loss
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#US EQUITIES
© 2026 Newsquawk. All rights reserved.
© 2026 Newsquawk. All rights reserved.